The 2 groups had different clinical data (patient 1: male, T1aN0M0, poorly differentiated HCC; patient 2: male, T1bN0M0, moderately differentiated HCC), both with high levels of FAP expression (Supplemental Fig. 3). Here, FAP is linked to hepatocellular carcinoma.